Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

HER3; MDA-BF-1; C-ErbB3; LCCS2; ErbB3-S; P180-ErbB3; P45-SErbB3; P85-SErbB3; Receptor Tyrosine-Protein Kinase ErbB-3; Lethal Congenital Contracture Syndrome 2

  • Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Packages (Simulation)
  • Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Packages (Simulation)
  • APC187Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

ACTIVITY TEST of the Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) is a member of the ErbB family of receptor tyrosine kinases. It is also known as human epidermal growth factor receptor 3 (HER3). ErbB3 plays a crucial role in various cellular processes including proliferation, differentiation, and survival. Neuregulin 1 (NRG1) is one of ligands of ErbB3, when NRG1 binds to ErbB3, it triggers dimerization and self-phosphorylation of the receptor, thereby activating downstream signaling pathways such as the PI3K/Akt and MAPK pathways. These signaling pathways are essential for cell growth and survival. Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human ErbB3 and recombinant human NRG1. Briefly, NRG1 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to ErbB3-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-NRG1 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630 nm immediately. When recombinant human ErbB3 is immobilized at 2 ug/mL (100 uL/well), the concentration of NRG1 that produces 50% optimal binding response is found to be approximately 0.14 ug/mL.

USAGE of the Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
UAPC187Hu01 Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Cell culture; Activity Assays.
URPC187Hu01 Recombinant V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Positive Control; Immunogen; SDS-PAGE; WB.
UPAC187Hu01 Polyclonal Antibody to V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) WB; IHC; ICC; IP.
UMAC187Hu21 Monoclonal Antibody to V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) WB; IHC; ICC; IP.
USEC187Hu ELISA Kit for V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMC187Hu Multiplex Assay Kit for V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK